Acupuncture for Symptoms of Nerve Damage

Not Applicable

Completed

• Conditions: Chemotherapy-induced Peripheral Neuropathy; Peripheral Neuropathy

• Registration Number: NCT03183037
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-07
• Study First Submitted: 2017-06-08
• Study First Submitted QC: 2017-06-08
• Study First Posted: 2017-06-09
• Status Verified: 2024-05
• Primary Completion: 2024-05-02
• Study Completion: 2024-05-02
• Last Update Submitted: 2024-05-02
• Last Update Posted: 2024-05-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

• English-speaking
• Age ≥ 18 years old
• Solid tumor survivors with no evidence of disease
• Moderate to severe CIPN, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale (NRS)
• Have completed neurotoxic chemotherapy at least 3 months prior to enrollment
• If taking anti-neuropathy medications, they are on a stable regimen (no change in 3 months)

Exclusion Criteria

• Patients with a pacemaker
• Prior acupuncture treatment within 5 years of enrollment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
change in the proportion of patients with a CIPN severity	up to 12 weeks	according to the NCI-CTC 4.0

Trial Locations

Locations (2)

Memorial Sloan Kettering Cancer Center @ Commack; 🇺🇸 Commack, New York, United States

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States